129
Views
11
CrossRef citations to date
0
Altmetric
Original Article

A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology

, , , , , , , , & show all
Pages 297-303 | Received 16 Jan 2012, Accepted 19 Apr 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tsutomu Takeuchi, Nobuyuki Miyasaka, Shinichi Kawai, Naonobu Sugiyama, Hirotoshi Yuasa, Noriaki Yamashita, Noriko Sugiyama, Lorin Craig Wagerle, Bonnie Vlahos & Joseph Wajdula. (2015) Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials. Modern Rheumatology 25:2, pages 173-186.
Read now

Articles from other publishers (10)

Fotios Drakopanagiotakis, Philipp Markart & Paschalis Steiropoulos. (2023) Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers. International Journal of Molecular Sciences 24:12, pages 10196.
Crossref
Toshihiko Hoashi, Shun Miyazaki, Saeko Ozaki, Susumu Ichiyama, Michiko Ito, Naoko Kanda & Hidehisa Saeki. (2023) Change in Serum KL-6 Level during Biologic Treatment for Psoriasis. Journal of Nippon Medical School 90:2, pages 194-201.
Crossref
Rida Siddique, Malik Hassan Mehmood, Muhammad Haris, Ammara Saleem & Zunera Chaudhry. (2022) Promising role of polymeric nanoparticles in the treatment of rheumatoid arthritis. Inflammopharmacology 30:4, pages 1207-1218.
Crossref
Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui & Shigeto Tohma. (2021) Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110225.
Crossref
Takashi Ono, Takuya Iwasaki, Yukiko Terada, Kentaro Abe, Jinhee Lee, Manabu Mochizuki & Kazunori Miyata. (2020) Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab. American Journal of Ophthalmology Case Reports 18, pages 100660.
Crossref
Takuya Masuda, Atsushi Yoshida, Fumiaki Ueno, Shintaro Hara, Haruaki Nabeta, Shotaro Umezawa, Mayuki Shirai, Yoshihide Morikawa, Toshio Morizane, Yutaka Endo & Toshifumi Hibi. (2019) A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFα. Inflammatory Intestinal Diseases 4:1, pages 35-40.
Crossref
Masahiro Kamata & Yayoi Tada. (2018) Safety of biologics in psoriasis. The Journal of Dermatology 45:3, pages 279-286.
Crossref
Koichi Yanaba, Yoshinori Umezawa, Reiko Sakakihara, Miki Chiba, Toshihiro Ito, Sota Kikuchi, Osamu Fukuchi, Akihiko Asahina, Hidehisa Saeki & Hidemi Nakagawa. (2015) Infliximab and adalimumab, unlike ustekinumab, increase serum KL ‐6 levels in Japanese patients with psoriasis . The Journal of Dermatology 42:8, pages 828-829.
Crossref
Atsushi Ogata, Kazuhide Tanimura, Toyohiko Sugimoto, Hiroshi Inoue, Yukitomo Urata, Tsukasa Matsubara, Masakazu Kondo, Yukitaka Ueki, Mitsuhiro Iwahashi, Shigeto Tohma, Shuji Ohta, Yukihiko Saeki & Toshio Tanaka. (2014) Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis. Arthritis Care & Research 66:3, pages 344-354.
Crossref
Kenji Takahashi, Hiroshi Nakamura, Kenji Takenouchi, Norishige Iizawa, Masahito Koiwa, Akiko Sato, Yusuke Mochizuki, Hiroshi Watanabe & Shinro Takai. (2014) Serum KL-6 Elevation and Possible Pulmonary Involvement in Patients with Rheumatoid Arthritis Treated with Biological Agents. Journal of Nippon Medical School 81:6, pages 364-371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.